588 related articles for article (PubMed ID: 14615445)
1. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
2. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
4. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
5. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
[TBL] [Abstract][Full Text] [Related]
6. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
7. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
[TBL] [Abstract][Full Text] [Related]
8. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.
Joly F; Alibhai SM; Galica J; Park A; Yi QL; Wagner L; Tannock IF
J Urol; 2006 Dec; 176(6 Pt 1):2443-7. PubMed ID: 17085125
[TBL] [Abstract][Full Text] [Related]
9. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
11. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
[TBL] [Abstract][Full Text] [Related]
14. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
Schagen SB; van Dam FS
J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
[No Abstract] [Full Text] [Related]
15. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.
Payne J; Piper B; Rabinowitz I; Zimmerman B
Oncol Nurs Forum; 2006 Jul; 33(4):775-83. PubMed ID: 16858459
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Fallowfield L; Cella D; Cuzick J; Francis S; Locker G; Howell A
J Clin Oncol; 2004 Nov; 22(21):4261-71. PubMed ID: 15514369
[TBL] [Abstract][Full Text] [Related]
18. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
20. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
